Table 1.
Definitions by various societies and its differences
Variables | APASL [1] | NASCELD [6] | EASL [4] |
---|---|---|---|
Defined patient group | First episode in compensated cirrhosis or non-cirrhotic CLD | Patients with acutely decompensated cirrhosis, with or without prior episode(s) of decompensation | Acute decompensation in cirrhosis patient with or without prior decompensation |
Acute insult | Hepatic only Variceal bleed is considered as insult if it results in liver failure | Extra-hepatic | Hepatic or extra-hepatic |
Variceal bleed is considered as precipitant | |||
Organ failure | Liver-central to pathogenesis | Any of the 4 | Any of 6 |
Cardiac (shock), hepatic encephalopathy, renal (need for dialysis), respiratory (need for mechanical ventilation) | Liver/cardiac/renal/circulatory/coagulant/respiratory | ||
Duration | Acute insult leading to development of ACLF with in 4 weeks | No specific duration specified | No specific duration specified |
Definition basis | Liver involvement is the central cause and subsequently other extrahepatic organ failures follow | Existence of 2 or more organ system failures | Based on existence of 1 of the six organ failures and CLIF-C score is used to categorize |
AARC score is used to stratify | |||
Mortality | Grade 1-13% | 2 OF-49% | Grade 1-20% |
Grade 2-45% | 3 OF-64% | Grade 2-30% | |
Grade 3-86% | 4 OF-77% | Grade 3-80% |
ACLF, acute on chronic liver failure; APASL, Asian pacific Association for study of liver; NASCELD, North American Consortium for the Study of End-Stage Liver Disease; EASL, European association of study of liver; AARC, APASL ACLF research consortium score; MELD, Model for end stage liver disease; CLIF C-ACLF, chronic liver failure consortium acute-on-chronic liver failure; CLD, chronic liver disease; OF, organ failure.